RxDoctor Payments Data

Walter Biffl, MD

Surgery · Denver, CONPI 1962408260

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Aroa Biosurgery Incorporated at 32.2% of the total. 2025 is the largest year on record at $529, more than ten times the $31 reported in 2019. That places this record below the midpoint for surgery clinicians in CO, where the typical reported total is $2,490.

$953in general payments, 2019–2025

Across 20 payments — averaging $47.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aroa Biosurgery Incorporated$306
  • AstraZeneca$231
  • Davol Inc.$92
  • Pacira Pharmaceuticals Incorporated$82
  • Johnson & Johnson$45
  • Histosonics, Inc.$35
  • plus $161 from 7 others
$13,425in research payments, 2019–2025

Across 2 payments — averaging $6712.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$13K

What the payments were for

  • Food & beverage$953100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$953 in reported general payments places this provider in the 40th percentile of 469 surgery providers in Colorado.

See all surgery providers in Colorado →

Medicare billing

Part B allowed, 2024
$34,719
Medicare patients
94
Services billed
279

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other surgery in Denver

See the full list for Colorado →

Where these figures come from

Is this you, or does something look wrong? →